Modulation of cell responsiveness to TGF-β can theoretically occur at any of the several steps of the signaling pathway from the membrane to gene-promoter regions, and mutations of several of the integral pathway components have been characterized in certain cancers [29-31]. This evidence concerns the gene TGFB1 and cancer.